ACADIA Pharmaceuticals, Inc. (ACAD)
21.40
-0.69
(-3.12%)
USD |
NASDAQ |
May 15, 16:00
21.31
-0.09
(-0.42%)
After-Hours: 20:00
ACADIA Pharmaceuticals Total Liabilities (Quarterly) : 357.16M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Insmed, Inc. | 1.371B |
| Madrigal Pharmaceuticals, Inc. | 683.87M |
| BioMarin Pharmaceutical, Inc. | 2.379B |
| MannKind Corp. | 803.60M |
| Regeneron Pharmaceuticals, Inc. | 9.445B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.605B |
| Shareholders Equity (Quarterly) | 1.248B |
| Debt to Equity Ratio | 0.0407 |
| Current Ratio | 3.587 |
| Net Debt Paydown Yield | 0.01% |